These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 24799481)

  • 41. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
    De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy.
    Vassilakopoulos TP; Pangalis GA; Chatziioannou S; Papageorgiou S; Angelopoulou MK; Galani Z; Kourti G; Prassopoulos V; Leonidopoulou T; Terpos E; Dimopoulou MN; Sachanas S; Kalpadakis C; Konstantinidou P; Boutsis D; Stefanoudaki E; Kyriazopoulou L; Siakantaris MP; Kyrtsonis MC; Variami E; Kotsianidis I; Symeonidis A; Michali E; Katodritou E; Kokkini G; Tsatalas C; Papadaki H; Dimopoulos MA; Sotiropoulos V; Pappa V; Karmiris T; Meletis J; Apostolidis J; Datseris I; Panayiotidis P; Konstantopoulos K; Roussou P; Rondogianni P
    Leukemia; 2016 Jan; 30(1):238-42. PubMed ID: 25971363
    [No Abstract]   [Full Text] [Related]  

  • 43. Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma.
    Tateishi U; Tatsumi M; Terauchi T; Ando K; Niitsu N; Kim WS; Suh C; Ogura M; Tobinai K
    Cancer Sci; 2015 Feb; 106(2):186-93. PubMed ID: 25495273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs.
    Wagner T; Brechemier D; Dugert E; Le Guellec S; Julian A; Hitzel A; Beyne-Rauzy O
    Cancer Imaging; 2012 Jan; 12(1):7-12. PubMed ID: 22275725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects.
    Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
    Acta Radiol; 2016 Jun; 57(6):733-41. PubMed ID: 26297729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma.
    Miyazaki Y; Nawa Y; Miyagawa M; Kohashi S; Nakase K; Yasukawa M; Hara M
    Ann Hematol; 2013 Jan; 92(2):239-44. PubMed ID: 23079891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
    Phan J; Mazloom A; Medeiros LJ; Zreik TG; Wogan C; Shihadeh F; Rodriguez MA; Fayad L; Fowler N; Reed V; Horace P; Dabaja BS
    J Clin Oncol; 2010 Sep; 28(27):4170-6. PubMed ID: 20713859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of negative interim 2-[¹⁸F]-fluoro-2-deoxy-d-glucose PET/CT in diffuse large B-cell lymphoma.
    Kwon SH; Kang DR; Kim J; Yoon JK; Lee SJ; Jeong SH; Lee HW; An YS
    Clin Radiol; 2016 Mar; 71(3):280-6. PubMed ID: 26732889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
    Zinzani PL; Martelli M; Bendandi M; De Renzo A; Zaccaria A; Pavone E; Bocchia M; Falini B; Gobbi M; Gherlinzoni F; Stefoni V; Tani M; Tura S
    Haematologica; 2001 Feb; 86(2):187-91. PubMed ID: 11224489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interim18 F-FLUORO-2-deoxy-d-glucose positron emission tomography scan/computed tomography scan in diffuse large B cell lymphoma-as a prognostic tool.
    Basit A; Siddiqui N; Muzaffar N; Awan UK; Bashir H; Khan SA; Hameed A
    J Pak Med Assoc; 2016 Apr; 66(4):380-6. PubMed ID: 27122261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase 2 Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-Cell Lymphoma.
    Kelsey CR; Broadwater G; James O; Chino J; Diehl L; Beaven AW; Chang C; Koontz BF; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):96-101. PubMed ID: 30858144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.
    Kostakoglu L; Goldsmith SJ; Leonard JP; Christos P; Furman RR; Atasever T; Chandramouly A; Verma S; Kothari P; Coleman M
    Cancer; 2006 Dec; 107(11):2678-87. PubMed ID: 17063502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value?
    Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
    J Comput Assist Tomogr; 2015; 39(5):810-5. PubMed ID: 26035406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach.
    Hayden AR; Tonseth P; Lee DG; Villa D; Gerrie AS; Scott DW; Freeman CL; Slack GW; Farinha P; Skinnider B; Yenson PR; Benard F; Lo A; Pickles T; Wilson D; Connors JM; Sehn LH; Savage KJ
    Blood; 2020 Dec; 136(24):2803-2811. PubMed ID: 32603413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.
    Dunleavy K; Little RF; Pittaluga S; Grant N; Wayne AS; Carrasquillo JA; Steinberg SM; Yarchoan R; Jaffe ES; Wilson WH
    Blood; 2010 Apr; 115(15):3017-24. PubMed ID: 20130244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment.
    Herrmann K; Buck AK; Schuster T; Junger A; Wieder HA; Graf N; Ringshausen I; Rudelius M; Wester HJ; Schwaiger M; Keller U; Dechow T
    J Nucl Med; 2011 May; 52(5):690-6. PubMed ID: 21498532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive value of interim ¹⁸F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment.
    González-Barca E; Canales M; Cortés M; Vidal MJ; Salar A; Oriol A; Bargay J; Bello JL; Sánchez JJ; Tomás JF; Donato E; Ferrer S; Caballero D;
    Nucl Med Commun; 2013 Oct; 34(10):946-52. PubMed ID: 23880897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
    Weihrauch MR; Re D; Scheidhauer K; Ansén S; Dietlein M; Bischoff S; Bohlen H; Wolf J; Schicha H; Diehl V; Tesch H
    Blood; 2001 Nov; 98(10):2930-4. PubMed ID: 11698273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of interim FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: Systematic review and meta-analysis.
    Adams HJ; Kwee TC
    Crit Rev Oncol Hematol; 2016 Oct; 106():55-63. PubMed ID: 27637352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
    Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
    Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.